Effect of nitric oxide synthase inhibition on intrarenal oxygenation as evaluated by blood oxygenation level-Dependent magnetic resonance imaging

Investigative Radiology

Volumn 44, Issue 2, 2009, Pages 67-73

  Li, Lu Ping ^a,b   Ji, Lin ^a,b   Santos, Elisabete A ^a,b   Prasad, Pottumarthi ^a,b,c   Dunkle, Eugene ^d   Pierchala, Linda ^d  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c EVANSTON HOSPITAL   (United States)

^d NONE

Author keywords

Hypertension; Kidney; MRI; Nitric oxide; Oxygenation

Indexed keywords

ARGININE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXYGEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; BLOOD OXYGENATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; RAT; TISSUE OXYGENATION; ANIMAL; BLOOD; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FEASIBILITY STUDY; HISTOLOGY; KIDNEY; METABOLISM; METHODOLOGY; OXIMETRY; SPRAGUE DAWLEY RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXIMETRY; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 66149145228     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181900975     Document Type: Article

References (39)

1. Kobori H, Nangaku M, Navar LG, et al. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251-287.
2. Majid DS, Kopkan L. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol. 2007;34:946-952.
3. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet. 2006;7:829-840.
4. Zanfolin M, Faro R, Araujo EG, et al. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in Rats. J Cardiovasc Pharmacol. 2006;47:391-395.
5. Wolzt M, Schmetterer L, Ferber W, et al. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Am J Physiol. 1997;272:F178-F182.
6. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59-64.
7. Ortiz MC, Fortepiani LA, Ruiz-Marcos FM, et al. Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition. Am J Physiol. 1998;274:R760-R766.
8. Mattson DL, Wu F. Control of arterial blood pressure and renal sodium excretion by nitric oxide synthase in the renal medulla. Acta Physiol Scand. 2000;168:149-154.
9. Mattson DL, Meister CJ. Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice. Am J Physiol Regul Integr Comp Physiol. 2005;289:R991-R997.
10. De Angelis K, Ogawa T, Sanches IC, et al. Impairment on cardiac output and blood flow adjustments to exercise in L-NAME-induced hypertensive Rats. J Cardiovasc Pharmacol. 2006;47:371-376.
11. Perregaux D, Chaudhuri A, Rao S, et al. Brachial vascular reactivity in blacks. Hypertension. 2000;36:866-871.
12. Djamali A, Sadowski EA, Muehrer RJ, et al. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am J Physiol Renal Physiol. 2007;292:F513-F522.
13. Djamali A, Sadowski EA, Samaniego-Picota M, et al. Noninvasive assessment of early kidney allograft dysfunction by blood oxygen level-dependent magnetic resonance imaging. Transplantation. 2006;82:621-628.
14. Han F, Xiao W, Xu Y, et al. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis. Nephrol Dial Transplant. 2008;23:2666-2672.
15. Juillard L, Lerman LO, Kruger DG, et al. Blood oxygen level-dependent measurement of acute intra-renal ischemia. Kidney Int. 2004;65:944-950.
16. Prasad PV. Evaluation of intra-renal oxygenation by BOLD MRI. Nephron Clin Pract. 2006;103:c58-c65.
17. Textor SC, Glockner JF, Lerman LO, et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol. 2008;19:780-788.
18. Thoeny HC, Kessler TM, Simon-Zoula S, et al. Renal oxygenation changes during acute unilateral ureteral obstruction: assessment with blood oxygen level-dependent MR imaging-initial experience. Radiology. 2008;247:754-761.
19. Thoeny HC, Zumstein D, Simon-Zoula S, et al. Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology. 2006;241:812-821.
20. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation. 1996;94:3271-3275.
21. Prasad PV, Epstein FH. Changes in renal medullary pO2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: effects of aging and cyclooxygenase inhibition. Kidney Int. 1999; 55:294-298.
22. Tumkur SM, Vu AT, Li LP, et al. Evaluation of intra-renal oxygenation during water diuresis: a time-resolved study using BOLD MRI. Kidney Int. 2006;70:139-143.
23. Prasad PV, Priatna A, Spokes K, et al. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging. 2001;13:744-747.
24. Li L, Storey P, Kim D, et al. Kidneys in hypertensive rats show reduced response to nitric oxide synthase inhibition as evaluated by BOLD MRI. J Magn Reson Imaging. 2003;17:671-675.
25. Hermann M, Flammer A, Luscher TF. Nitric oxide in hypertension. J Clin Hypertens (Greenwich). 2006;8:17-29.
26. Avontuur JA, Biewenga M, Buijk SL, et al. Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock. Shock. 1998;9:451-454.
27. Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, et al. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med. 1998;26:660-667.
28. Kiehl MG, Ostermann H, Meyer J, et al. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive Care Med. 1997;23:561-566.
29. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension. 1999;33:937-942.
30. Watson D, Grover R, Anzueto A, et al. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebocontrolled multicenter study (study no. 144-002). Crit Care Med. 2004;32: 13-20.
31. Wecht JM, Weir JP, Goldstein DS, et al. Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure. Am J Physiol Heart Circ Physiol. 2008;294:H190-H197.
32. Wecht JM, Weir JP, Krothe AH, et al. Normalization of supine blood pressure after nitric oxide synthase inhibition in persons with tetraplegia. J Spinal Cord Med. 2007;30:5-9.
33. Barer G, Emery C, Stewart A, et al. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J Physiol. 1993;463:1-16.
34. Braun RD, Lanzen JL, Snyder SA, et al. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am J Physiol Heart Circ Physiol. 2001;280:H2533-H2544.
35. Liss P, Nygren A, Revsbech NP, et al. Intrarenal oxygen tension measured by a modified Clark electrode at normal and low blood pressure and after injection of x-ray contrast media. Pflugers Arch. 1997;434:705-711.
36. Rudolf Hebel MWS. Anatomy and Embryology of the Laboratory Rat. Wörthsee, Bavaria: BioMed Verlag; 1986:65.
37. dos Santos EA, Li LP, Ji L, et al. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol. 2007;42:157-162.
38. Delles C, Jacobi J, Schlaich MP, et al. Assessment of endothelial function of the renal vasculature in human subjects. Am J Hypertens. 2002;15:3-9.
39. Pippa Storey LJ, Lu-Ping Li, Pottumarthi VP. Detection of blood volume changes in the rat kidney using an intravascular USPIO contrast agent. In: Proceedings of 14th Scientific Meeting of the International Society for Magnetic Resonance in Medicine; 2006; Seattle, Washington.